Celanese Corporation produces and sells engineered polymers worldwide through its Engineered Materials and Acetyl Chain segments. Its products include a wide range of polymers, resins, and chemicals for applications in automotive, construction, consumer goods, electronics, medical, and other industries. The company markets its products under numerous brands and sells directly to customers and through distributors, as well as to original equipment manufacturers and suppliers. It has a strategic partnership with VIGOR Precision Ltd. Founded in 1912, Celanese Corporation is headquartered in Irving, Texas.
Citi downgrades Dow and LyondellBasell to Neutral on weak chemical demand
Citi downgraded Dow and LyondellBasell to Neutral from Buy on Wednesday, citing weak demand that is limiting the benefit chemical producers might otherwise receive from higher oil and global feedstock costs. Lead analyst Patrick Cunningham said Citi no longer has conviction that polyethylene prices offer significant upside, even with crude oil at $100 a barrel, and the firm cut earnings estimates and price targets across much of its North American commodity chemicals coverage. Citi lowered its Dow price target to $30 from $35 and its LyondellBasell target to $63 from $72, and reduced its 2027 EPS estimate for Dow to $1.21 from $1.83 and for LyondellBasell to $5.79 from $7.20. The firm expects integrated polyethylene margins to decline by about 11 cents per pound in 2027, with each 1-cent change representing roughly $120 million in annualized EBITDA for Dow's North American operations and $133 million for LyondellBasell. Citi also cut its Westlake price target to $67 from $85 while maintaining a Neutral rating, trimmed its Celanese target to $58 from $60 and its Eastman Chemical target to $76 from $81 while keeping Buy ratings on both, and maintained Neutral/High Risk ratings on Huntsman and Olin with price targets cut to $9 from $11 and $17 from $19, respectively.
DOW · Capital · Negative Citi downgraded Dow to Neutral from Buy and cut its price target to $30 from $35 and 2027 EPS estimate to $1.21 from $1.83.
LYB · Capital · Negative Citi downgraded LyondellBasell to Neutral from Buy and cut its price target to $63 from $72 and 2027 EPS estimate to $5.79 from $7.20.
CE · Capital · Negative Citi trimmed its Celanese price target to $58 from $60 while keeping a Buy rating.
EMN · Capital · Negative Citi cut its Eastman Chemical price target to $76 from $81 while keeping a Buy rating.
HUN · Capital · Negative Citi maintained a Neutral/High Risk rating on Huntsman and cut its price target to $9 from $11.
OLN · Capital · Negative Citi maintained Neutral/High Risk on Olin and cut its price target to $17 from $19 amid weak chemical demand.
Celanese Corporation announced price increases across four acetyl products on September 21, effective immediately or as contracts and other commitments permit. The action covers acetic acid, vinyl acetate monomer, ethyl acetate, and acetic anhydride, with increases of $0.06 per pound for vinyl acetate monomer and $0.045 per pound for each of the other three products in the United States and Canada, plus specified increases for Mexico, South America, Europe, the Middle East and Africa. The company pointed to recent pricing momentum: second-quarter Acetyl Chain net sales reached $1.33 billion, up 28% sequentially, with reported price and volume increases of 22% and 6%, respectively, and segment operating profit of $237 million at an 18% reported operating margin. Celanese also said it expected supply-related opportunities to continue moderating in the third quarter, and the announcement does not establish how much of the increase the company will ultimately collect given contract terms, negotiated concessions, discounts, and possible customer switching. Insider Monkey's database showed 48 hedge funds holding Celanese at the end of 2Q2026, down from 49 funds three months earlier.
CE · Pricing · Positive Celanese raised prices on four acetyl products (acetic acid, VAM, ethyl acetate, acetic anhydride), a direct price hike on its own products.
Celanese Appoints Luis Fernandez-Moreno to Board of Directors
Celanese appointed Luis Fernandez-Moreno to its Board of Directors, adding over 40 years of industry experience to the US-based chemicals group. Fernandez-Moreno has held senior roles across major chemical producers, with a focus on performance materials and industrial chemicals, and his background spans corporate strategy, growth initiatives and product innovation across multiple global operations in the sector. Celanese produces engineered polymers used in everything from cars to electronics, and the company carries a market value of about $5.2 billion. The appointment is one piece of the broader Celanese story, with the company's path tied to cost optimisation, integration of acquired assets and product diversification toward more sustainable materials. Investors can watch coming quarterly reports and management commentary for evidence on consolidating production sites, capturing targeted synergies in Engineered Materials and keeping debt service and interest coverage aligned with balance sheet risk.
CE · Regulation · Neutral Celanese appointed Luis Fernandez-Moreno to its Board of Directors, a governance change with no clear near-term financial impact.
Celanese to Sell Another 19% of Nutrinova to Mitsui for $152 Million
Celanese Corporation agreed to sell an additional 19% of the Nutrinova food-ingredients joint venture to Mitsui & Co., Ltd. for approximately $152 million in cash, a deal expected to close in the fourth quarter subject to customary conditions. The sale will cut Celanese's retained interest in Nutrinova from 30% to 11%, and the interest being sold generated roughly $4 million of equity earnings in 2025, meaning the consideration equals about 38 times that contribution. Proceeds will reduce debt, fund upcoming maturities, and count toward Celanese's goal of generating $1 billion from divestitures by the end of 2027; combined with the completed $500 million Micromax divestiture, the two announced deals total approximately $652 million, about 65% of that objective. Celanese ended 2025 with approximately $11.3 billion of company-defined non-GAAP net debt and targets about $10 billion by the end of 2026 and below $9 billion by the end of 2027, while aiming for $700 million to $800 million of company-defined non-GAAP free cash flow in 2026. Under the related diketene-facility arrangement, Nutrinova will cover the facility's full purchase price and ongoing operating costs, leaving Celanese with no funding obligation.
CE · Capital · Positive Celanese sells an additional 19% of Nutrinova to Mitsui for ~$152M, with proceeds reducing debt and advancing its $1B divestiture goal.
8031.JP · Capital · Positive Mitsui agrees to buy an additional 19% of the Nutrinova JV from Celanese for ~$152M.
Nutrinova · · Neutral Nutrinova is the JV whose stake is being sold, but the article gives no standalone impact on Nutrinova itself.
Celanese to Sell Additional 19% of Nutrinova Stake to Mitsui for $152M
Celanese Corporation has agreed to sell an additional 19% stake in its Nutrinova food ingredients joint venture to Mitsui & Co., Ltd. for $152 million in cash, reducing its ownership to 11% while strengthening its balance sheet. The transaction, which contributed about $4 million in equity earnings in 2025, will allow Celanese to continue participating in the food ingredients business. Proceeds will be used to reduce net debt and repay upcoming maturities, supporting its goal of $1 billion in divestiture proceeds by the end of 2027. As part of the deal, Celanese will temporarily operate a diketene production facility in Frankfurt before transferring it to Nutrinova, with Mitsui covering the purchase price and operating costs. The transaction is subject to customary closing conditions.
CE · Capital · Positive Celanese sells an additional 19% Nutrinova stake to Mitsui for $152M cash, using proceeds to cut net debt and repay maturities toward its $1B divestiture goal.
8031.JP · Capital · Positive Mitsui buys an additional 19% of Nutrinova for $152M, raising its stake and covering the Frankfurt diketene facility's purchase price and operating costs.
Nutrinova · · Neutral Nutrinova is the JV whose stake is being transferred, but the article gives no independent operational or financial impact on the venture itself.
Celanese and VIGOR partner on lightweight plastic joints for humanoid robots
Celanese Corporation and VIGOR Precision Ltd. have signed a strategic partnership agreement to develop and commercialize lightweight plastic joint solutions for humanoid robots. Under the agreement, Celanese will supply VIGOR with targeted high-performance plastic materials and technical support, aiming to reduce joint module weight by more than 30 percent by replacing traditional metals. The partnership focuses on overcoming technical challenges in high strength, temperature resistance, precision transmission, and dimensional accuracy. VIGOR CEO Hoi-sang Chan and Celanese Senior Vice President Todd Elliott attended the signing ceremony at Celanese's Shanghai Commercial and Technology Center.
Celanese wins dismissal of damages claim in Amsterdam court
Celanese reported that the Amsterdam District Court dismissed damages claims in a major legal dispute, removing a significant legal overhang. The ruling dismissed claims brought by Shell Chemicals Europe B.V. and parties represented by Stichting Ethylene Claims, eliminating potential financial liability linked to a high-profile European Commission settlement. The decision simplifies the risk picture for Celanese, which recently reported Q2 2026 sales of US$2,752 million and net income of US$125 million, compared with US$2,532 million and US$197 million a year earlier. The stock closed at US$43.89 and has seen pronounced volatility, with the share price down over 60% across the past three years and over 70% across five years.
Celanese Corp. reported a drop in second-quarter profit. Net earnings fell to $125 million, or $1.13 per share, from $197 million, or $1.80 per share, a year earlier. Adjusted earnings rose to $2.45 per share from $1.43 per share last year. Net sales increased to $2.75 billion from $2.53 billion, reflecting a 4% increase in volume and a 14% increase in price. For the third quarter, Celanese expects adjusted earnings of $1.35 to $1.75 per share, and it continues to expect full-year adjusted earnings of about $6.00 per share.
Amsterdam District Court Dismisses All Claims Against Celanese in Shell and Repsol Cases
The Amsterdam District Court has dismissed in their entirety the damages claim brought by Shell Chemicals Europe and a declaratory judgment claim from certain Repsol entities against Celanese and its co-defendants. Both claims arose from follow-on litigation related to a 2020 settlement with the European Commission over past ethylene purchases in North-Western Europe. Celanese stated that the decisions confirm its position that the claimants are not entitled to recover damages and that it will continue to defend against remaining claims in Dutch and German courts.
Celanese Corporation Declares Quarterly Dividend of $0.03 Per Share
Celanese Corporation declared a quarterly cash dividend of $0.03 per share on its common stock. The dividend is payable on August 10, 2026, to stockholders of record as of July 28, 2026. Celanese is a global chemical and specialty materials company with 2025 net sales of $9.5 billion.
Turtle Creek Says Celanese Benefits from Low-Cost US Natural Gas Advantage
Turtle Creek Asset Management highlighted Celanese Corporation as having a significant competitive edge due to its disproportionate use of low-cost U.S. natural gas in production, according to the firm's first-quarter 2026 investor letter. Celanese, a global specialty chemical and materials company, was the portfolio's largest detractor after reporting weaker-than-expected EBITDA and EPS, yet it continued to generate substantial free cash flow. Turtle Creek noted that higher global feedstock costs, such as natural gas, amplify Celanese's advantage. The stock closed at $51.23 on June 17, 2026, with a market capitalization of $5.62 billion, and 49 hedge funds held the name at quarter-end, up from 42 in the prior quarter.
Celanese Partners With Siegwerk to Advance Bio-Based Printing Ink Solutions
Celanese Corporation has partnered with Siegwerk to increase the supply of sustainable solutions in the printing ink value chain. The collaboration uses Celanese's bio-based ethyl acetate, which contains 50% renewable content, as a drop-in solution in Siegwerk's existing ink formulations to support its SustainUP program under the HorizonNOW 2030 sustainability strategy. The partnership aims to reduce environmental impact while maintaining performance standards and advancing circular solutions in a practical and scalable way. Celanese shares have lost 4.5% over the past year against the industry's 8.7% growth.
United States
